Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

7.84
-0.3000-3.69%
Post-market: 7.840.00000.00%16:10 EDT
Volume:533.80K
Turnover:4.21M
Market Cap:134.11M
PE:-2.03
High:8.42
Open:8.22
Low:7.68
Close:8.14
52wk High:16.77
52wk Low:7.68
Shares:17.11M
Float Shares:15.72M
Volume Ratio:1.81
T/O Rate:3.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.62
PE(LYR):-2.46

Loading ...

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

prnewswire
·
May 14

EVEREST MED Shares Climb Over 3% Following Release of Initial Human Data for mRNA Cancer Vaccine EVM16

Stock News
·
May 14

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

GlobeNewswire
·
May 14

Thalia Therapeutics CEO Outlines Strategic Pivot to High-Value RNA Therapies

TIPRANKS
·
May 13

Capital Universities Strengthen Role as Pillars in Fundamental Research

Deep News
·
May 13

Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

GlobeNewswire
·
May 12

ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances

TIPRANKS
·
May 12

ProQR Announces First Quarter 2026 Operating and Financial Results

GlobeNewswire
·
May 12

ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform

GlobeNewswire
·
May 11

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 07

WA biotech duo takes aim at diabetes beyond Ozempic

The West Australian
·
May 07

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

GlobeNewswire
·
May 04

ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors

GlobeNewswire
·
Apr 30

ArcticZymes Wins Key Patent to Drive Expansion in RNA Therapeutics Manufacturing

TIPRANKS
·
Apr 30

Circio Teams With TraffikGene on Non-Viral Delivery for Circular RNA Therapies

TIPRANKS
·
Apr 29

CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation

GlobeNewswire
·
Apr 28

Wave Life Sciences Reports Q1 Results, Advances RNA Pipeline

TIPRANKS
·
Apr 28

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Apr 28

Circio’s circVec Gene Therapy Platform Wins Spotlight at Global ASGCT Meeting

TIPRANKS
·
Apr 28

Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

Dow Jones
·
Apr 28